retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial Diagram showing the mechanism of action of Retatrutide: How Triple GLP-1/GIP/Glucagon Receptor
Description
Contemporary classification of Glucagon-like peptide 1 receptor agonists (GLP1RAs)
Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial
doi: 10.3233/JAD-143090 170 Perez-CruzCNolteMWvan GaalenMMRustayNRTermontATangheAet al
Access GLP-1 treatments, skincare medications, and more
In clinical trials, patients lost on average 25 kg
Acoustic dispensing preserves the potency of therapeutic peptides throughout the entire drug discovery workflow
